Michael J. Farrell - Aug 17, 2023 Form 4 Insider Report for RESMED INC (RMD)

Role
Chief Executive Officer
Signature
Michael J. Farrell, Chief Executive Officer
Stock symbol
RMD
Transactions as of
Aug 17, 2023
Transactions value $
$0
Form type
4
Date filed
8/18/2023, 02:02 PM
Previous filing
Aug 17, 2023
Next filing
Sep 19, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RMD ResMed Common Stock Award $0 +12.4K +2.84% $0.00 449K Aug 17, 2023 Direct F1
holding RMD ResMed Common Stock 0 Aug 17, 2023 Lisette and Michael Farrell Foundation
holding RMD ResMed Common Stock 4.09K Aug 17, 2023 Lisette and Michael Farrell Family Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents performance-based restricted stock units granted on November 16, 2022. The shares were earned on August 17, 2023, when the compensation committee certified that the performance metrics were met. Stock units vest 1/3 each year on the anniversary of the grant.